DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME7KNX8

Market Closed - Börse Stuttgart 19:22:30 25/06/2024 BST
166.6 EUR +0.25% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+2.01%
1 month+2.13%
Date Price Change
25/06/24 166.6 +0.25%
24/06/24 166.2 -0.29%
21/06/24 166.6 +0.22%
20/06/24 166.3 +0.54%
19/06/24 165.4 -0.24%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 07:22 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7KNX
ISINDE000ME7KNX8
Date issued 25/01/2024
Maturity 20/09/2024 (87 Days)
Parity 1 : 1
Emission price 162.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 166.6
Lowest since issue 158.1
Spread 0.08
Spread %0.05%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.9 USD
Average target price
279.2 USD
Spread / Average Target
+19.38%
Consensus